Tapan Kadia, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    DAVA Oncology
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Jazz Pharmaceuticals
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sellas
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    DrenBio
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Delta-Fly Pharma
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Hikma Pharmaceuticals
    Date added:
    09/06/2023
    Date updated:
    09/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Date added:
    09/06/2023
    Date updated:
    09/06/2023

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice